Treatment Selection Choices Should Not Be Based on Benefits or Costs Alone: A Head-to-Head Randomized Controlled Trial of Antiviral Drugs for Hepatitis C

BACKGROUND: Clinicians often face dilemmas with decisions related to formulary choices when two similar drugs are simultaneously available in the market. We studied the comparative safety, effectiveness, and treatment costs of the two first generation direct-acting antiviral agents (DAA), boceprevir...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:PLoS One
Hoofdauteurs: Davitkov, Perica, Chandar, Apoorva Krishna, Hirsch, Amy, Compan, Anita, Silveira, Marina G., Anthony, Donald D., Smith, Suzanne, Gideon, Clare, Bonomo, Robert A., Falck-Ytter, Yngve
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Public Library of Science 2016
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5065164/
https://ncbi.nlm.nih.gov/pubmed/27741230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0163945
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items